Omaha, NE, United States of America

Xin Wei

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Wei. Retrieved from https://idiyas.com/inventor/xin-wei-94lju5oz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xin Wei

Introduction

Xin Wei is an accomplished inventor based in Omaha, NE (US). She has made significant contributions to the field of drug delivery systems. Her innovative work focuses on developing novel platforms that enhance the efficacy of therapeutic agents.

Latest Patents

Xin Wei holds a patent for a macromolecular prodrug-based thermosensitive injectable gel. This innovative drug delivery platform, known as ProGel, comprises conjugates of dmg molecules with water-soluble polymeric carriers. The ProGel is designed for controlled release of the dmg molecules into the tissue of a subject. The patent also discloses the use of ProGel-drug conjugates for the treatment of various diseases or disorders, along with methods for preparing them.

Career Highlights

Xin Wei is affiliated with the Board of Regents of the University of Nebraska. Her work at this institution has allowed her to explore and develop cutting-edge technologies in drug delivery. She has demonstrated a commitment to advancing medical science through her research and innovations.

Collaborations

Xin Wei collaborates with notable colleagues, including Zhenshan Jia and Steven R Goldring. These partnerships enhance her research efforts and contribute to the development of innovative solutions in her field.

Conclusion

Xin Wei's contributions to drug delivery systems exemplify the impact of innovative thinking in medicine. Her patent for the ProGel platform represents a significant advancement in therapeutic delivery methods. Through her work, she continues to push the boundaries of what is possible in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…